Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine and oral sucrose for pain relief during eye examination for retinopathy of prematurity in preterm infants
TCTR20240503003Phase 3Not yet recruiting
- Sponsor
- Siriraj Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in procedural pain, sponsored by Siriraj Hospital. Planned start May 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
procedural pain
Beyond the preview
Go deeper on TCTR20240503003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240503003.